ASO Author Reflections: Should We Be Using Dextrose-Containing Carrier Solutions for Perfusion During HIPEC?
ASO Author Reflections
- 41 Downloads
The authors have no conflicts of interest to disclose.
- 4.Turaga K, Levine E, Barone R et al. Consensus guidelines from the American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States. Ann Surg Oncol. 2014; 21:1501–1505.CrossRefGoogle Scholar
© Society of Surgical Oncology 2018